Intage Holdings Inc. TSE:4326
INTAGE : Explanation Materials for Consolidated Financial Results for the Six Months Ended December 31, 20252032KB
Source: MarketScreener
Financial results presentation for institutional investors and analysts
Explanation Materials for Consolidated Financial Results for the Six Months Ended December 31, 2025INTAGE HOLDINGS Inc.
Securities code: 4326
February 9, 2026
Sales saw a slight decrease. While panel research in the core businesses continued to grow steadily, the decline was due to factors such as the transfer of the CRO business in the previous fiscal year. Although the growth businesses expanded compared to the previous year, they fell short of the plan, resulting in performance below the initial forecast. Operating profit improved in profitability across all segments, finishing above both the previous year and the forecast. Profit attributable to owners of the parent decreased due to the absence of gains recorded from the CRO business transfer.
Consolidated Statement of Income(Millions of yen)
6 months ended Dec. 31, 2024 | 6 months ended Dec. 31, 2025 | Change from previous year | YoY | 2Q Forecast | |
Net sales | 32,027 | 31,688 | △338 | △1.1% | 32,500 |
Operating expenses | 30,245 | 29,324 | △921 | △3.0% | - |
Operating profit | 1,781 | 2,363 | +582 | +32.7% | 2,000 |
Ordinary profit | 1,744 | 2,381 | +636 | +36.5% | 2,000 |
Profit attributable to owners of parent | 2,017 | 1,220 | △797 | △39.5% | 1,000 |
EPS (yen) | 52.88 | 31.95 | - | - | 26.20 |
Summary of Consolidated Statements of Income
2
Operating profit increased significantly, benefitting from continued profit-oriented management initiatives and the elimination of the duplicate cost burden of SCI.
(Millions of yen)
1,781
345
186
-17
-339
2,363
407
2,500
2,000
1,500
1,000
500
0
Operating profit for 6 months ended December 31, 2024
Lower sales Variable costs Personnel
expenses
Costs Investment Operating profit for 6 months ended December 31, 2025
Net sales Personnel expenses
Investment
Sales decreased due to the transfer of the CRO business and the rebound effect from large-scale projects of INTAGE RESEARCH Inc. and Buildsystem Co.,Ltd in the previous fiscal year.
Increased due to salary revisions and other factors. But the overall level remained broadly in line with the previous fiscal year as a result of a decrease of employees by the transfer of the CRO business.
Decreased due to the completion of the transition to the new SCI.
Factors Contributing to Changes in Operating Profit
3
Other Overseas
Co
CR
Panel surveys
Net sales breakdown by product (Millions of yen)
24/12 | 25/12 | Y/Y | Operating profit margin | |
Net sales | 21,691 | 21,790 | +0.5% | |
Operating profit | 227 | 630 | +177.5% | 2.9% |
(Millions of yen)
2,597 | +8% | 2,800 |
2,741 | ▲1% | 2,720 |
1,810 | ▲18% | 1,483 |
7,177 | +0% | 7,180 |
7,363 | +3% | 7,606 |
24/12
25/12
Other: Public-sector projects, RnI's CODE, etc.Overseas: Sales from overseas subsidiaries (excluding healthcare)
Co: Communications area (i-SSP, Media Gauge, di-PiNK, etc.)
CR-Web: Internet surveys of custom research areas
Panel surveys: SRI+, SCI, etc.
Despite the reactionary impact from the large-scale projects recorded in the previous year at INTAGE RESEARCH Inc., the segment achieved revenue growth.
Panel surveys expanded, driven by price increases and the acquisition of new contracts.
In the advertising domain, service demand fluctuates in short cycles, leading to a decline in certain products in the Co category. Advertising-related services jointly promoted with NTT DOCOMO span multiple product categories, with steady progress in winning new projects.
In addition to increased revenue from highly profitable panel surveys, the completion of the transition to the new SCI enabled operating profit to significantly exceed the previous year's level.
Financial Results Highlights
From this fiscal year onward, "CR-WEB" and "CR (Other than WEB)" have been consolidated and disclosed as "CR."
From the second quarter, we reclassified a portion of panel survey items to "Other" to better reflect actual conditions.
©INTAGE GROUP
Performance by Segment: Marketing Support (Consumer Goods & Services)
4
Other Promotion
CRO
CR
Panel surveys
Net sales breakdown by product
307
313
1,382
328
0
2,735
2,715
2,126
1,874
+1%
1,299
▲6%
+13%
(Millions of yen)
24/12 | 25/12 | Y/Y | Operating profit margin | |
Net sales | 6,609 | 6,474 | △2.0% | |
Operating profit | 1,186 | 1,547 | +30.4% | 23.9% |
(Millions of yen)
24/12
Due to the impact of the CRO business divestiture, revenue declined.
Panel research recorded significant year-on-year growth, supported by the acquisition of new contracts and price increases across product lines, with particularly strong contributions from the expansion of the prescription database provided by INTAGE Real World Inc.
While CR services continued to perform steadily, Promotion at Kyowa Kikaku Co., Ltd. fell below the previous year's level.
Although sales decreased, profitability improved, resulting in operating profit significantly exceeding that of the previous year.
Financial Results Highlights
25/12
Other: Healthcare sales of overseas subsidiaries, etc.Promotion: Sales from promotion-related business conducted by KYOWA KIKAKU, Ltd.
CRO (Contract Research Organization)*: Post-marketing surveillance, etc.
CR: Custom research mainly for pharmaceutical companies and medical device manufacturers
Panel surveys: SRI+, Impact Track, prescription database, etc.
* As noted in the disclosure dated June 17, 2024, effective September 2, 2024 the CRO Business was transferred to Alfresa Holdings Corporation.
©INTAGE GROUP
Performance by Segment: Marketing Support (Healthcare)
5
DX
BPO
Net sales breakdown by area
952
966
1,506
1,235
896
1,596
▲6%
+8%
(Millions of yen)
24/12 | 25/12 | Y/Y | Operating profit margin | |
Net sales | 3,726 | 3,423 | △8.1% | |
Operating profit | 367 | 185 | △49.5% | 5.4% |
SI
(Millions of yen)
24/12
▲23%
DX fell below the previous year due to a rebound effect from low-code development projects at Build System Inc., although the data integration and utilization business remained solid. SI also fell below the previous year due to a decline in projects from certain clients in the travel industry.
Operating profit declined due to lower sales, in addition to the one-time expenses associated with the consolidation and relocation of the Nagano office conducted in November 2025.
Financial Results Highlights
25/12
companies' sales information systems, publishing POS systems, trade area analyses, AI solutions.
Examples of solutions
INTAGE TECHNOSPHERE provides IT solutions. The company's business includes building and operating systems, and
managing data centers.
Payment systems for travel agencies, health management support services, pharmaceutical
INTAGE TECHNOSPHERE Inc. business lineup
DX: Support for promotion of DX-related areas in companies
BPO: BPO services such as business process efficiency improvement, system maintenance and management, etc.SI: System development, etc.
Performance by Segment: Business Intelligence
6
Management Strategy Topics
14th Medium-Term Management Plan and the FY2025 Business Plan 8
14th Medium-Term Management Plan
Priority Issues
(FY2023-FY2025)
Basic Policy
- Creation of new value -
Group Strategy | Expanding business value with a goal of Toward 2030 |
Data Strategy | Promote a data strategy that increases the value of the company's data even as the market changes |
Technology Strategy | Continue to take on the challenge of data utilization and DX support and cross industry boundaries |
Co-creation Strategy | Promote group co-creation to support the creation of new value |
Basic Policy
FY2025 Business Plan
Priority Issues
Growth with Optimization
Establishment of a new business portfolio
1
Expanding business value with a goal of Toward 2030
2 | Engage in business operations with a clear business portfolio (growth with optimization) |
3 | Shift to an optimal formation to enhance overall group capabilities |
©INTAGE GROUP
Shift toward business operations with clear core businesses and growth businesses
Develop new services and solutions and create synergies
with DOCOMO
Future possibilities ◎
Large investments will allow for growth in new areas.
Key points
Sales
expansion
Generate projects in areas with growth potential
Emphasis on
results
Quick launch of new services.
Growth Businesses
Traditional marketing research such as panel surveys and
custom research
Future possibilities ▲
Sales continue to increase, but it is difficult to expect large growth.
Key points
Emphasis on
profit
Practice management focused on profit over sales
Offered value
Improved value to clients, price increases, etc.
Core Businesses
Leading the way to growth while maintaining balance
Shift from optimization of individual companies to a formation which enhance overall group capabilities.
Aim to create an organization that readily allows optimal allocation of business resources.
Allocate profits generated by core businesses to growth businesses that will lead to medium to long-term growth.
©INTAGE GROUP
Management Policy - Growth with Optimization -
9
For continued growth as a Data + Technology company with a goal ofToward 2030
EBPM - Initiatives to Expand the NTT Group's Urban Development Business - 10
SUGATAMI is provided as part of the SSPP (Sustainable Smart City Partner Program) promoted by the NTT Group to support municipal management and community development. Its purpose is to maximize regional and resident well-being and to visualize the attractiveness of the
community. By enabling an objective understanding and self-recognition of both the municipality's desired future state and its current conditions, the tool contributes to resident-centric municipal management and community development that leverages unique local characteristics, incorporating new value standards beyond economic measures (i.e., human-centered values).
Providing "SUGATAMI Reports": Urban data that reflects the current state of the city
NTT's unique set of 18 urban functionality domains
Levels of resident satisfaction with their city that could not be captured through conventional surveys
Analysis of residents' well-being together with satisfaction levels and urban functionality
Leveraging the strengths of the INTAGE Group to promote the commercialization of "SUGATAMI"
Starting in 2025, the Group will take the lead in operations related to SUGATAMI, a solution provided through the NTT Group's SSPP initiative.
Using report-related tasks-such as resident surveys, data collection and
processing, and system-related support-as a foundation, the Group will move
forward with:
exploring business models that leverage these reports,
conducting PoC initiatives in collaboration with municipalities,
and pursuing full-scale commercialization in the next phase.
Interpreting SUGATAMI data:
Supporting urban development through a broad and comprehensive scope
Detailed analysis of unique, city-specific data
Supporting planning efforts that help cities move toward their ideal future, based on an understanding of current conditions
Providing diverse support, including dispatching specialists and developing human resources
Convenient and affluent society free from social loss
Citizens, Government, Enterprises
Solving Social Issues Resident's Well-being Sustainable Economy
Transportation Logistics Consumption Economy Tourism Healthcare Education Urban Development
Governance
Action
Solution Solution Solution Solution Solution Solution Solution Solution
NTT Group
Suppor t
SUGATAMI Reports
※1 :EBPM(Evidence Based Policy Making)
※2 :SSPP(Sustainable Smart City Partner Program)https://digital-is-green.jp/
A project that supports the next generation of community development, aimed at maximizing the well-being of local communities and residents.It provides
a forum where members from industry, academia, government, and citizens can co-create sustainable and self-reliant frameworks, along with a wide range of solutions, technologies, and expertise that leverage the unique characteristics of each region.
©INTAGE GROUP
We have launched the first overseas consumer panel in Vietnam. We aim to establish this as a new growth driver in overseas business, which had primarily been custom research until now.
Overview of i-Panel
UpdateSales Update
Channel Coverage Main Categolies
Launched in October 2025
Monitor
Consumers in Vietnam (in five cities including Ho Chi Minh and Hanoi)
Sample size
6,000ss
Data collected
Shopping data on daily necessities, etc.
Way of collection
Receipt and Barcode Scanning
Implementation confirmed by multiple foreign and Japanese consumer goods manufacturers
Development Update
Currently approaching primarily Japanese and Vietnamese consumer goods manufacturers
Supermarket, Mini-mart Convenience Store, Pharmaceutical
Grocery Store, Wet Market, Food Stall, Street Vendor Stall
FMCG
Hotel, Restaurant, Café, Milk Tea, Bakery
Shopee, Tiktok Shop, Lazada, Tiki, Grab, Be, etc.
Restaurant
Pharmaceutical
Electronics
Customized dashboards for existing clients
Preparing the product master to enable the expansion of product categories
Meeting strong demand for consumer panels and driving early adoption
Fashion & Lifestyle Entertainment
Launch of the Consumer Panel (i-Panel) in Vietnam
11
In the consumer goods manufacturers that are clients of INTAGE, business needs related to medical care, health, and beauty are expanding. By co-creating solutions that leverage the medical domain assets and expertise held by INTAGE Healthcare -such as data utilization and analytics- we can better meet the broad range of consumer needs that these manufacturers aim to address.
Consumer Profiles as Business Targets
Development of New Products and Services
Repurposing and Leveraging Existing Technologies
and Ingredients
Development of Products
Purchase Behavior of 70,000 Consumers
Plamed Doctor Monitor
Insights on medical settings, diseases, and patients
Pre-patient population
Disease prevention
Business Needs
Health
and Services Requiring Specialized Evidence and Expertise
Market trends based on sales data from 6,000 stores nationwide
Understand the symptoms and diseases from the perspective of healthcare consumers and patients
Utilizing disease-specific treatment insights for physician targeting
Research Themes and Needs
Development of apps that support healthy lifestyles
Understanding the pre-patient population for developing functional foods
Actual conditions of skin troubles
Realities of health, beauty, lifestyle-related diseases, and exercise therapy
Understanding on-site conditions in clinical and rehabilitation settings
Usage status of medical devices
Desire to utilize survey results from physicians
Medical
Beauty
INTAGE ×
INTAGE Healthcare
consumer goods manufacturers (clients of INTAGE)
Enabling proposals based on a comprehensive understanding of consumers
Value Creation through Group Co-Creation
- Expanding Cross-Segment Proposals -
12
Forecasts Capital Policy
Based on the performance through the second quarter and the outlook for the business environment going forward, the full-year earnings forecast remains unchanged. Each segment will continue efforts to generate new projects for the third quarter, which is the peak season for their core and growth businesses.
(Millions of yen)
6 months ended Dec. 31, 2025 (Ⓐ) | Forecasts for the FY June 30, 2026 (Ⓑ) | Progress | Ⓑ - Ⓐ | (Reference) FY25/6 Second-Half Results | ||
Full Year | Net sales | 31,688 | 70,000 | 45.3% | 38,312 | 33,544 |
Operating profit | 2,363 | 5,600 | 42.2% | 3,237 | 2,460 | |
Ordinary profit | 2,381 | 5,500 | 43.3% | 3,119 | 2,387 | |
Profit attributable to owners of parent | 1,220 | 3,200 | 38.1% | 1,980 | 1,488 | |
Marketing Support (Consumer Goods & Services) | Net sales | 21,790 | 49,100 | 44.4% | 27,310 | 23,653 |
Operating profit | 630 | 2,700 | 23.3% | 2,070 | 1,208 | |
Marketing Support (Healthcare) | Net sales | 6,474 | 13,200 | 49.0% | 6,726 | 5,823 |
Operating profit | 1,547 | 2,400 | 64.4% | 853 | 947 | |
Business Intelligence | Net sales | 3,423 | 7,700 | 44.5% | 4,277 | 4,068 |
Operating profit | 185 | 500 | 37.0% | 315 | 305 | |
The above forecast has been prepared based on information that is currently available to the Company and is subject to high levels of uncertainty. Actual results may differ from the forecast.
Forecasts for the Fiscal Year Ending June 30, 2026
14
Marketing Support (Consumer Goods & Services) |
|
Marketing Support (Healthcare) |
|
Business Intelligence |
|
Business Environment for Each Segment and Outlook for Second half of FY2025
15
Expansion of business/increase in market expectations
Attaching importance to capital efficiency, allocate total final profit to "shareholder return" and "growth investment"
Precondition: Ratings BBB+
01
Shareholder return:
50% or more
(Target the year ending June 30, 2026)
02
Growth investment
Expense-related Investment
(business investment, R&D, etc.)
Asset-related investment (tangible and intangible assets, M&A, etc.)
Long-term corporate value enhancement
ROE
12%-
Dividends
Acquisition of treasury shares
Profit
Depreciation equivalent
Borrowing (when needed)
Operating profit
Capital Policy
16
Dividend Policy 17
Based on our basic policy on profit distribution, for the fiscal year ending June 30, 2026, the increase in dividend will continue, with a dividend of 48 yen, an increase of 3 yen.
EPS (earnings per share) (yen) | Dividend per share (yen) | Dividend payout ratio (consolidated) (%) | ROE (return on equity) (%) | |||
2Q | Year-end | Total | ||||
Year ended June 30, 2022 | 86.31 | - | 38.00 | 38.00 | 44.0 | 11.3 |
Year ended June 30, 2023 | 91.21 | - | 42.00 | 42.00 | 46.0 | 11.4 |
As of June 30, 2024 | 64.47 | - | 43.00 | 43.00 | 66.7 | 7.8 |
As of June 30, 2025 | 91.83 | 22.50 | 22.50 | 45.00 | 49.0 | 10.7 |
Year ending June 30, 2026 (Planned) | 83.80 | 24.00 | 24.00 | 48.00 | 57.3 | 9.4 |
Our basic policy is to distribute profits based on consolidated business performance, which is the result of Group management, while maintaining a balance between dividends and investment for growth. The Company aims to achieve a consolidated dividend payout ratio of 50% and ROE (return on equity) of 12% for the final fiscal year ending June 30, 2026. In addition, the Company will take flexible action regarding the acquisition of treasury shares in order to improve capital efficiency.
The Company's basic policy is to pay dividends from its surplus twice a year, an interim dividend and a year-end dividend.
For FY2026/6, operating profit is expected to increase significantly (from 4.24 billion yen to 5.6 billion yen). However, profit attributable to owners of parent is expected to decrease due to a reactionary decrease from gains on sale of the CRO business recorded in FY2025/6, resulting in an expected ROE of 9.4%.
From FY2027/6 onward, we aim to achieve ROE of around 12% through continuous profit growth.
Recognition of Current Status
The Future
2.50
Trends in ROE and PBR
15.00%
2.00
1.50
10.00%
1.00
0.50
5.00%
0.00
2018.3 2019.3 2020.6 2021.6 2022.6 2023.6 2024.6 2025.6 2026.6
資本コ スト
Cost of Capital
PBR ROE0.00%
©INTAGE GROUP
ROE Trends and Cost of Capital
18
We recognize that the cost of shareholders' equity has been in the 5%-8% range (we conservatively use 8.0% as our cost of capital for internal use)
For FY2025/6, ROE was 10.7% and PBR was 2.0x, an improvement from the previous fiscal year. This level is comparable to the period excluding FY2020/6, which was affected by the COVID-19 pandemic, and FY2024/6, which saw a temporary increase in expenses related to the parallel operation of the old and new SCI systems, and the capital and business alliance with DOCOMO. ROE has returned to a level exceeding the cost of capital (approx. 10-13%) and PBR has returned to a level of 1.2-2.0x.
appendix
Commenced deliberation on group reorganization as part of organizational restructuring aimed at building an optimal structure to realize the Group Vision 2030.
Background and Rationale
To realize our Vision 2030, we determined that fundamental organizational reforms are necessary to expand into new growth domains beyond our traditional business areas.
Accordingly, we aim to eliminate barriers between business segments and transition to a structure that maximizes profitability through the optimal allocation of management resources.
Purpose of the Integration
Develop an organizational infrastructure that will enable the Company to realize new business value
Solve customer issues through company-wide value creation
Integration Schedule(Planned)
Early August 2026 :Resolution to approve proposed organizational structure
July 1, 2027 :Start of new organization operation
The integration scheme and organizational structure will be announced once finalized.
Method of Integration
Examine the optimal structure of the Group, focusing on the integration of the three core segment companies*.
Prior to the Group reorganization, INTAGE Real World Inc., a wholly owned subsidiary of INTAGE Healthcare Inc., will be merged into INTAGE Healthcare Inc. effective July 1, 2026.
*INTAGE Inc., INTAGE Healthcare Inc., and INTAGE TECHNOSPHERE Inc.
Regarding the Disclosure on February 5
Commencement of Deliberation on Group Reorganization Focusing on Integration of Consolidated Subsidiaries
21
2 years have now passed since the launch of the distribution data integration and analysis service POS-is®. POS-is is being increasingly adopted by mainly consumer goods manufacturers.
Number of service adopters (including tentative introduction)15
8
10
Optimizes sales and manufacturing activities by automatically integrating POS data that differs by retailer and combining it with INTAGE's panel data and shipping data
POS
data
Site providing POS for each company/business
* No external provision of data is required as entire solution from
integrated platform to dashboard is built within customer environment.
Transaction data
Shipment and delivery data
INTAGE
master data
Demand forecasting
Inventory control
Promotional
investment management
Distribution management
INTAGE
market data
POS analysis
Formatted data
Formatting
and processing program
KPI management
BI tools Sales applications
Data integration platform
Customer-owned data
24/12 25/6 25/12
Data integration
UpdateAcceleration of Industry Standardization
Through the full automation of analysis, not only has "productivity reform" been achieved, but its value as a "data-driven business transformation engine" - one that enables the standardization and advancement of proposals - has also been recognized, leading to growing adoption among top-tier companies in the industry.
Enhancement of Provided Value
In addition to conventional analysis, we are developing new features for implementation next fiscal year, such as inventory optimization and promotional ROI visualization, which enable improvements in cash flow and maximization of profits.
Distribution Data PF The Growing POS-is® Service Integrating POS Data and Optimization Sales and Manufacturing Activities
22
Data utilization support in the healthcare domain is performing strongly 23
The adoption of Cross Fact, the integrated medical database provided by INTAGE Real World Inc., which holds three types of medical receipt (reimbursement claim) data, continues to perform strongly. By leveraging a wide range of fact-based data, we provide solution-driven proposals tailored to the needs of pharmaceutical companies, thereby promoting more effective data utilization.
Fact Data
dispensing claim receipts
Social insurance claim receipts
NDB※1
Data from the claims review and payment organizations
Data from insurance-covered pharmacies (outpatient prescriptions)
Others
pharmaceutical master data
DPC data※2
Data from medical institutions
Integrated Medical Database
Cross Fact
High-Speed Processing / Scaled Estimation
Solution
Patient-Derived Sales
Dynamic Market Share
Regional mesh data (area analysis)
History Chart (Patient Journey)
Regimen analysis
/ line analysis※3
and more
※1 National Data Base:A database used for surveys and analyses related to the formulation, implementation, and evaluation of medical cost optimization plans, storing and organizing data such as medical claim information and specific health checkup/specific health guidance information. ※2 Diagnosis Procedure Combination ※3 Analysis of drug combinations and treatment sequences.
©INTAGE GROUP
Accelerating Alliances to Become a Data + Technology Company
Aim: Create touchpoints with advanced technologies and services
Overview: Established with SBI Investment Co., Ltd. Total amount generated: 5 billion yen Operation period: October 2016 through March 2027
Features of investment:
The fund is operated based on the fund features (sourcing, business evaluation, monitoring, etc.) provided by SBI Investment Co., Ltd. By having INTAGE Group employees actively participate throughout the sourcing phase, they gain expertise in business evaluation, network with venture companies and serve as a channel for collecting information. This helps improve the effectiveness of alliance activities.
Investment results: 2.85 billion yen has been invested in 28 companies (as of December 2025)
Investing companies (as of December 2025)
Marketing
Research and Innovation Co., Ltd.
Payke, Inc. XICA CO.,LTD.
BitStar Inc.
Healthcare
Dr. JOY Co., Ltd.
Ubie Inc.
FiNC Technologies Inc. CureApp, Inc.
Platform
EverySense, Inc. Tamer Inc. ambr, Inc.
AI
Cross Compass Ltd. Godot Inc.
Life
every, Inc. Alice. style, Inc.
Image and video
technologies
EmbodyMe, Inc.
* Invested in three other companies (company names not disclosed)
Exit results: IPO: four companies, M&A: five companies
Investment examples
Operates the shopping information registration app "CODE"
Invested in November 2017, and made a subsidiary of INTAGE, Inc. in May 2021
We are utilizing the company's proprietary technology for reading receipts in SCI renewal
Develops medical DX services such as the symptom search engine "Ubie" used by over
12 million people per month
Invested in November 2020
We are considering collaborations with our healthcare segment
About INTAGE Open Innovation Fund
24
Summary of Consolidated Balance Sheets | 24/12 | 25/12 | Increase/ Decrease |
Current assets | 30,533 | 30,438 | -94 |
Non-current assets | 16,389 | 16,729 | +340 |
Total assets | 46,922 | 47,168 | +245 |
Current liabilities | 12,567 | 12,330 | -236 |
Non-current liabilities | 1,034 | 1,018 | -15 |
Total liabilities | 13,601 | 13,349 | -252 |
Total net assets | 33,321 | 33,818 | +497 |
Total assets | 46,922 | 47,168 | +245 |
Summary of Consolidated Statements of Cash Flows Cash flows from operating activities | 24/6 | 25/12 |
482 | -2,034 | |
Cash flows from investing activities | 1,400 | -523 |
Cash flows from financing activities | -1,776 | -1,056 |
Effect of exchange rate change on cash and cash equivalents | -20 | 46 |
Net increase (decrease) in cash and cash equivalents | 86 | -3,567 |
Cash and cash equivalents at beginning of period | 11,940 | 16,492 |
Cash and cash equivalents at end of period | 12,026 | 12,924 |
Net cash provided by (used in) operating activities
Due to the seasonality of revenue recognition, accounts receivable collection becomes concentrated in the second half of the year, resulting in negative operating cash flow.
Net cash provided by (used in) investment activities
Investment cash flow turned to a net outflow, mainly due to increased investment in business-related software development at ITG and ITSP.
Net cash provided by (used in) financing activities
As a result of the interim dividend system introduced in the previous fiscal year, dividend payments decreased year on year, resulting in a net outflow in financing cash flow.
Summary of Consolidated Balance Sheets and Consolidated Statements of Cash Flows
(Millions of yen)
25
(Millions of yen)
17,609
18,918
16,969
17,327
16,432
15,057
14,306
14,361
14,930
14,625
20,000
Trend in net sales
(Millions of yen)
Trend in operating profit
18,000
16,000
3,000
2,486
1,778
1,791
1,594
1,331
572
198
-19
-27
187
2,500
14,000
2,000
12,000
1,500
1,000
10,000
500
8,000
1Q(7~9) 2Q(10~12) 3Q(1~3) 4Q(4~6)
0
-500
1Q(7~9) 2Q(10~12) 3Q(1~3) 4Q(4~6)
Year ended June 30, 2024
Year ended June 30, 2025
Year ending June 30, 2026
Trend in quarterly results
26
Quarterly net sales breakdown by product
27
3Q(Cumulative) | 3Q(Noncumulative) | 4Q(Cumulative) | 4Q(Noncumulative) | ||||||||||
(Millions of yen) | Year ended June Year ended June Year ending June 30, 2024 30, 2025 30, 2026 | Year ended June Year ended June Year ending June 30, 2024 30, 2025 30, 2026 | Year ended June Year ended June Year ending June 30, 2024 30, 2025 30, 2026 | Year ended June Year ended June Year ending June 30, 2024 30, 2025 30, 2026 | |||||||||
C G & S | Panel Surveys | 11,920 | 11,779 | 4,096 | 3,991 | 16,088 | 16,043 | 4,168 | 4,264 | ||||
CR | 10,006 | 11,393 | 3,819 | 4,213 | 12,471 | 14,213 | 2,465 | 2,820 | |||||
Co | 1,885 | 2,673 | 708 | 878 | 2,435 | 3,435 | 550 | 762 | |||||
Overseas | 4,260 | 4,393 | 1,630 | 1,652 | 5,374 | 5,710 | 1,114 | 1,317 | |||||
Other | 3,512 | 5,125 | 2,091 | 2,941 | 4,805 | 5,940 | 1,293 | 815 | |||||
H C | Panel Surveys | 2,756 | 2,832 | 915 | 958 | 3,712 | 3,811 | 956 | 979 | ||||
CR | 3,480 | 3,960 | 984 | 1,245 | 4,688 | 4,969 | 1,208 | 1,009 | |||||
CRO | 1,979 | 324 | 583 | 0 | 2,577 | 324 | 598 | 0 | |||||
Promotion | 2,110 | 2,017 | 640 | 635 | 2,780 | 2,751 | 670 | 734 | |||||
Other | 430 | 465 | 153 | 153 | 577 | 575 | 147 | 110 | |||||
B I | SI | 2,536 | 2,040 | 720 | 744 | 3,187 | 2,593 | 651 | 553 | ||||
BPO and maintenance | 1,637 | 1,774 | 581 | 719 | 2,087 | 2,418 | 451 | 644 | |||||
DX | 1,831 | 2,166 | 688 | 790 | 2,492 | 2,784 | 661 | 618 | |||||
Quarterly net sales breakdown by product
28